University of Heidelberg
Faculty of Medicine Mannheim
University Hospital Mannheim
These pages are still under constructions and will be available soon! Please check again later!

If you have questions concerning a specific publication please use this form with subject 'information about publications' and giving the full citation in the message body.

Collaborate Research Projects
Home > Publications > Abstract >

Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency

A. Schulze, G. Hoffmann, P. Bachert, S. Kirsch, G. Salomons, N. Verhoeven and E. Mayatepek

Neurology, 67 (4), pp.719-721

Prospective observation in a neonate with guanidinoacetate methyltransferase deficiency (GAMT-D), a severe neurometabolic disorder, revealed increased guanidinoacetate levels at birth. After 14-month treatment with creatine, high-dose ornithine, benzoate, and an arginine-restricted diet, the patient's development is normal and she does not present any symptoms of GAMT-D. The authors' observation indicates that early detection of GAMT-D is possible in the neonatal period, and presymptomatic treatment may prevent its manifestation.

Contact: Dr. Frank Zöllner last modified: 30.09.2020
to top of page